1
Nagle Advait, Gray Nathanael Schiander, Liu Yi, Ren Pingda, Sim Taebo, You Shuli: Compounds and compositions as protein kinase inhibitors. Irm, Nagle Advait, Gray Nathanael Schiander, Liu Yi, Ren Pingda, Sim Taebo, You Shuli, KONZAK Kristin E, November 23, 2006: WO/2006/124462 (66 worldwide citation)

The invention provides a novel class of compounds, pharmaceutical compositions comprising such compounds and methods of using such compounds to treat or prevent diseases or disorders associated with abnormal or deregulated kinase activity, particularly diseases or disorders that involve abnormal act ...


2
Michellys Pierre Yves, Pei Wei, Marsilje Thomas H, Lu Wenshuo, Chen Bei, Uno Tetsuo, Jin Yunho, Jiang Tao: Compounds and compositions as protein kinase inhibitors. Irm, Michellys Pierre Yves, Pei Wei, Marsilje Thomas H, Lu Wenshuo, Chen Bei, Uno Tetsuo, Jin Yunho, Jiang Tao, TONGCO WU Emily, June 19, 2008: WO/2008/073687 (58 worldwide citation)

The invention provides novel pyrimidine and pyridine derivatives of formula (I) and pharmaceutical compositions thereof, and methods for using such compounds. For example, the pyrimidine and pyridine derivatives of the invention may be used to treat, ameliorate or prevent a condition which responds ...


3
Ding Qiang, Sim Tae Bo, Zhang Guobao, Adrian Francisco, Gray Nathanael S: Novel compounds and compositions as protein kinase inhibitors. Irm, Ding Qiang, Sim Tae Bo, Zhang Guobao, Adrian Francisco, Gray Nathanael S, GARRETT WACKOWSKI Eugenia, October 21, 2004: WO/2004/089286 (52 worldwide citation)

The invention provides a novel class of compounds, pharmaceutical compositions comprising such compounds and methods of using such compounds to treat or prevent diseases or disorders associated with abnormal or deregulated tyrosine kinase activity, particularly diseases associated with the activity ...


4
Choi Ha Soon, Wang Zhicheng, Gray Nathanael Schiander, Gu Xiang Ju, He Xiaohui, He Yun, Jiang Tao, Liu Yi, Richmond Wendy, Sim Taebo, Yang Kunyong: Compounds and compositions as protein kinase inhibitors. Irm, Choi Ha Soon, Wang Zhicheng, Gray Nathanael Schiander, Gu Xiang Ju, He Xiaohui, He Yun, Jiang Tao, Liu Yi, Richmond Wendy, Sim Taebo, Yang Kunyong, REID Scott W, September 1, 2005: WO/2005/080393 (43 worldwide citation)

The invention provides a novel class of compounds, pharmaceutical compositions comprising such compounds and methods of using such compounds to treat or prevent diseases or disorders associated with abnormal or deregulated kinase activity, particularly diseases or disorders that involve abnormal act ...


5
Ren Pingda, Wang Xia, Zhang Guobao, Ding Qiang, You Shuli, Zhang Qiong, Chopiuk Greg, Albaugh Pamela A, Sim Taebo, Gray Nathanael Schiander: Compounds and compositions as protein kinase inhibitors. Irm, Ren Pingda, Wang Xia, Zhang Guobao, Ding Qiang, You Shuli, Zhang Qiong, Chopiuk Greg, Albaugh Pamela A, Sim Taebo, Gray Nathanael Schiander, REID Scott, December 29, 2005: WO/2005/123719 (37 worldwide citation)

The invention provides a novel class of compounds, pharmaceutical compositions comprising such compounds and methods of using such compounds to treat or prevent diseases or disorders associated with abnormal or deregulated kinase activity, particularly diseases or disorders that involve abnormal act ...


6
Ding Qiang, Xie Yongping, Gray Nathanael Schiander, You Shuli, Chopiuk Greg, Jiang Jiqing, Liu Yi, Steensma Ruo, Wang Xing, Sim Taebo: Compounds and compositions as protein kinase inhibitors. Irm, Ding Qiang, Xie Yongping, Gray Nathanael Schiander, You Shuli, Chopiuk Greg, Jiang Jiqing, Liu Yi, Steensma Ruo, Wang Xing, Sim Taebo, REID Scott W, April 21, 2005: WO/2005/034869 (33 worldwide citation)

The invention provides a novel class of compounds, pharmaceutical compositions comprising such compounds and methods of using such compounds to treat or prevent diseases or disorders associated with abnormal or deregulated kinase activity, particularly diseases or disorders that involve abnormal act ...


7
Ren Pingda, Gray Nathanael S, Wang Xia, Zhang Guobao: Compounds and compositions as protein kinase inhibitors. Irm, Ren Pingda, Gray Nathanael S, Wang Xia, Zhang Guobao, REID Scott W, September 28, 2006: WO/2006/101783 (29 worldwide citation)

The invention provides a novel class of compounds, pharmaceutical compositions comprising such compounds and methods of using such compounds to treat or prevent diseases or disorders associated with abnormal or deregulated kinase activity, particularly diseases or disorders that involve abnormal act ...


8
Sim Taebo, Lee Hyun Soo, Ren Pingda, Ding Qiang, Wang Xia, Uno Tetsuo, Zhang Guobao, Liu Yi, Li Bing, Li Lintong, Gray Nathanael S, You Shuli: Compounds and compositions as protein kinase inhibitors. Irm, Sim Taebo, Lee Hyun Soo, Ren Pingda, Ding Qiang, Wang Xia, Uno Tetsuo, Zhang Guobao, Liu Yi, Li Bing, Li Lintong, Gray Nathanael S, You Shuli, REID Scott, February 10, 2005: WO/2005/011597 (27 worldwide citation)

The invention provides a novel class of compounds, pharmaceutical compositions comprising such compounds and methods of using such compounds to treat or prevent diseases or disorders associated with abnormal or deregulated kinase activity, particularly diseases or disorders that involve abnormal act ...


9
Ren Pingda, Gray Nathanael S, Wang Xia, Zhang Guobao, Sim Taebo, Jiang Songchun: Compounds and compositions as protein kinase inhibitors. Irm, Ren Pingda, Gray Nathanael S, Wang Xia, Zhang Guobao, Sim Taebo, Jiang Songchun, REID Scott W, November 23, 2006: WO/2006/124731 (20 worldwide citation)

The invention provides a novel class of compounds, pharmaceutical compositions comprising such compounds and methods of using such compounds to treat or prevent diseases or disorders associated with abnormal or deregulated kinase activity, particularly diseases or disorders that involve abnormal act ...


10
Chopiuk Greg, Furet Pascal, Gray Nathanael Schiander, Imbach Patricia, Liu Yi, Schoepfer Joseph, Steensma Ruo: Compounds and compositions as protein kinase inhibitors. Irm, Novartis, Chopiuk Greg, Furet Pascal, Gray Nathanael Schiander, Imbach Patricia, Liu Yi, Schoepfer Joseph, Steensma Ruo, REID Scott W, April 14, 2005: WO/2005/033086 (19 worldwide citation)

The invention provides a novel class of compounds, pharmaceutical compositions comprising such compounds and methods of using such compounds to treat or prevent diseases or disorders associated with abnormal or deregulated kinase activity, particularly diseases or disorders that involve abnormal act ...